Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
GF CSI Innovative Drugs Industry ETF
GF CSI Innovative Drugs Industry ETF (515120) Latest Quoted at RMB 0.62, Net Inflows of RMB 750 Million Over 9 Consecutive Days
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-09-10
ETF Financing Ranking | GF CSI Innovative Drugs Industry ETF (515120) had a net financing buy-in of CNY 33.38 million on Sep 2
Tags:
GF CSI Innovative Drugs Industry ETF
515120.SH
NewTimeSpace
2026-09-03
ETF Financing Ranking | GF CSI Innovative Drugs Industry ETF (515120) had a net financing buy-in of CNY 14.5 million Sep 1
Tags:
GF CSI Innovative Drugs Industry ETF
515120.SH
NewTimeSpace
2026-09-02
GF CSI Innovative Drugs Industry ETF (515120) fell 1.87%, with AUM increasing by RMB 2.478 billion over the past three months
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-14
GF CSI Innovative Drugs Industry ETF (515120) rose 2.18%, with its scale increasing by RMB 78.1496 million over the past 1 week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-13
GF CSI Innovative Drugs Industry ETF (515120) Rises 2.47%, with Scale Growing by RMB 393 Million Over the Past Week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-11
GF CSI Innovative Drugs Industry ETF (515120) Rises 3.24%, with Scale Growing by RMB 636 Million Over the Past Week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-10
GF CSI Innovative Drugs Industry ETF(515120) Falls 1.23%, with Latest Net Capital Outflow of RMB 89.0930 Million
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-06
GF CSI Innovative Drugs Industry ETF(515120) Falls 1.74%, with Share Count Growing by 81 Million Units Over the Past Week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-08-03
GF CSI Innovative Drugs Industry ETF(515120) Rises 0.80%, with Share Count Growing by 156 Million Units Over the Past Week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-27
GF CSI Innovative Drugs Industry ETF(515120) rises 2.28%, aiming for a third consecutive gain
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-22
GF CSI Innovative Drugs Industry ETF (515120) rises 5.18%, with a share increase of 431 million units over the past 2 weeks
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-15
GF CSI Innovative Drugs Industry ETF(515120) rises 4.35%, with a scale increase of 2.082 billion yuan over the past 2 weeks
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-10
GF CSI Innovative Drugs Industry ETF(515120) rises 1.27%, with a net inflow of 1.036 billion yuan over the past 5 trading days
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-02
GF CSI Innovative Drugs Industry ETF(515120) rises 3.65%, with the latest net inflow of 396 million yuan
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-07-01
GF CSI Innovative Drugs Industry ETF(515120) rises 2.49%, aiming for a fourth consecutive gain
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-06-24
GF CSI Innovative Drugs Industry ETF (515120) rises 1.50%, with a share increase of 11.00 million units over the past week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-06-10
ETF Financing Ranking | GF CSI Innovative Drugs Industry ETF (515120) had a net financing buy-in of CNY 11.91 million, ranked first among comparable funds-20260602
Tags:
GF CSI Innovative Drugs Industry ETF
515120.SH
2026-06-03
GF CSI Innovative Drugs Industry ETF(515120) Falls 1.59%, Sees Net Inflow of 212 Million Yuan Over the Past 5 Trading Days
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-05-13
GF CSI Innovative Drugs Industry ETF (515120) Rises 3.23%, Sees Share Growth of 114 Million Units Over the Past Week
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-04-28
1
2
Next
Featured News
Finance
SHENYANG PUBLIC (00747.HK): Disposes of 100% Equity Interest in Target Company for RMB 2 Million, Expects Gain of About RMB 33.55 Million
Finance
SF INTRA-CITY (09699.HK): Non-Executive Director Lei Yanqun Resigns
Finance
NEWLINK TECH (09600.HK): Termination of Memorandum of Intent on Equity Acquisition; Proposed Acquisition Will Not Proceed
Finance
LANCANG TEA (06911.HK): Subsidiary's RMB 24.9 Million Working Capital Loan Extended by One Year, Company Continues to Provide Guarantee
Overseas
Going Global Weekly: Mainland Companies Flock to Hong Kong Listings, Pharma Globalisation Shifts to Data and Capability Export-20260918
Finance
TRANSTHERA-B (02617.HK): Tinengotinib Included in CSCO Guidelines for Biliary Tract Malignancies (2026)
Finance
IMAGI INT'L (00585.HK): Change of Audit Committee Chairman — Tam Man Hong Succeeds Miao Xi
Finance
IMPACT THERAP-B (07630.HK): Sepalna Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Ovarian Cancer
Finance
CISI FIN (06058.HK): Discloseable Transaction — Subsidiary Disposes of USD 20.15 Million Notes, Recording a Gain of About USD 165,407
Finance
S HARBOURHOLD (01663.HK): Chairman and Substantial Shareholder Wang Linbing Acquires 3.89 Million Shares at Average Price of About HKD 0.056
Scan QR Code
Download App